Evidence map›Paper›PMID 17882224›Full record

ArticleGenes and immunity2007

Novel mutations in a Japanese patient with CD19 deficiency.

H Kanegane, K Agematsu, T Futatani, M M Sira, K Suga, T Sekiguchi, M C van Zelm, T Miyawaki

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 132 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. miR-31-5p suppresses myocardial hypertrophy by targeting Nfatc2ip.Journal of cellular and molecular medicine · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Combination of celecoxib (CelebrexAmerican journal of clinical and experimental immunology · 2017
    Review
  14. Article
  15. Review
  16. Review
  17. Common Variable Immunodeficiency and Circulating TFH.Journal of immunology research · 2016
    Article
  18. Article
  19. Article
  20. Rare variants at 16p11.2 are associated with common variable immunodeficiency.The Journal of allergy and clinical immunology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

H KaneganeDepartment of Pediatrics, Graduate School of Medicine, University of Toyama, Toyama, Japan. kanegane@med.u-toyama.ac.jp
K Agematsu
T Futatani
M M Sira
K Suga
T Sekiguchi
M C van Zelm
T Miyawaki
University of Toyama · JPTakamatsu Red Cross Hospital · JPErasmus MC · NLShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is a heterogeneous disorder characterized by recurrent bacterial infections, hypogammaglobulinemia and low to normal numbers of circulating B cells. Mutations in the ICOS, TACI and CD19 genes have recently been identified in <10% of CVID patients. We, herein, describe two novel CD19 gene disruptions in an 8-year-old Japanese boy, who had been clinically diagnosed as having CVID at the age of 5 years. Flow-cytometric analysis demonstrated absence of CD19 and reduced CD21 expression on CD20-postive peripheral blood B cells. Mutation analysis of CD19 revealed a mutation in the splice acceptor site of intron 5 (IVS5-1G>T) of the maternal allele, resulting in skipping of exon 6, and a truncated protein product. The paternal allele was disrupted by a gross deletion encompassing at least the ATP2A1, CD19 and NFATC2IP genes. The patient had a small number of IgD(-) CD27(+) memory B cells, in which somatic mutation were detected. His B cells showed substantial proliferation upon stimulation, but reduced IgG and IgA production in vitro. These findings extend the mutation spectrum of the CD19 deficiency to four, and confirm the homogeneity of the CD19 deficiency as a unique type of CVID.

Indexed as

Amino Acid SequenceAntigens, CD19Antigens, CD20Asian PeopleB-LymphocytesChildCommon Variable ImmunodeficiencyHumansImmunoglobulin DImmunologic MemoryMaleMolecular Sequence DataMutationNFATC Transcription FactorsReceptors, Complement 3dRNA Splice SitesAntigens, CD19Antigens, CD20ATP2A1 protein, humanImmunoglobulin DNFATC2 protein, humanNFATC Transcription FactorsReceptors, Complement 3dRNA Splice SitesSarcoplasmic Reticulum Calcium-Transporting ATPasesTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID17882224
OpenAlexW1972853120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.